Skip to main content
Premium Trial:

Request an Annual Quote

Research Council of Norway Awards Genpoint $1.5M to Expand DNA Prep System

NEW YORK, March 3 (GenomeWeb News) - The Research Council of Norway has awarded Genpoint $1.5 million over three years to expand the company's Bugs 'n Beads DNA-preparation kit for use on additional microorganisms, the company said today.

 

The FUGE program contributed about $1 million to the company, while the PROSBIO program contributed the remainder. The FUGE acronym stands for "National Plan of Functional Genomics," while PROSBIO stands for "Innovation Program for the Process and Bio-medical Industry."

 

The company will expand its Beads 'n Bugs system, which isolates DNA from pathogenic bacteria in clinical samples and "other complex solutions," so that it can be isolated from Chlamydia and Mycoplasma, Genpoint said.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.